Low-dose cytarabine
Drug timelines are a Plus or Pro feature.
16 regulatory and trial events tracked for Low-dose cytarabine, covering 2012-08-01 to 2026-02-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Cladribine, Low Dose Cytarabine, and Venetoclax in Treatment of Relapsed/Refractory or Secondary Acute Myeloid Leukemia [Phase 2]